Transgender hormone therapy (female-to-male) to individuals taking bioidentical hormones in the form of testosterone (including esters) and do not apply to those taking synthetic AAS (e.g., nandrolone) or dihydrotestosterone. Transgender hormone therapy (female-to-male) Transgender hormone therapy of the female-to-male (FTM) type, also known as masculinizing hormone therapy, is a form of hormone therapy and sex reassignment therapy which is used to change the secondary sexual characteristics of transgender people from feminine (or androgynous) to masculine. It is one of two types of transgender hormone therapy (the other being male-to-female), and is predominantly used to treat transgender men and other transmasculine individuals. Some intersex people
Sexual bimaturism Sexual bimaturism Sexual bimaturism describes a difference in developmental timing between males and females of the same species. Sexual bimaturism can result in sexual dimorphism, but sexual dimorphism could also develop through differential rates of development. In many insects, the larval period of females is longer than that of males, and as a result of this extended growth period, these female insects are larger than their male conspecifics. Male simian primates are generally larger than females of the same species due in part to extended growth periods. Gorillas demonstrate a particularly high degree of sexual bimaturism. Bimaturism can refer to